Exploring the Role of Non-coding RNAs in Atrial Septal Defect Pathogenesis: A Systematic Review

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2024 Aug 22

PMID 39172906

Authors

Zahra Amirsardari

Akram Gholipour

Zahra Khajali

Majid Maleki

Mahshid Malakootian

Affiliations

Soon will be listed here.

Abstract

Background: Extensive research has recognized the significant roles of non-coding RNAs (ncRNAs) in various cellular pathophysiological processes and their association with diverse diseases, including atrial septal defect (ASD), one of the most prevalent congenital heart diseases. This systematic review aims to explore the intricate involvement and significance of ncRNAs in the pathogenesis and progression of ASD.

Methods: Four databases (PubMed, Embase, Scopus, and the Web of Science) were searched systematically up to June 19, 2023, with no year restriction. The risk of bias assessment was evaluated using the Newcastle-Ottawa scale.

Results: The present systematic review included thirteen studies with a collective study population of 874 individuals diagnosed with ASD, 21 parents of ASD patients, and 22 pregnant women carrying ASD fetuses. Our analysis revealed evidence linking five long ncRNAs (STX18-AS1, HOTAIR, AA709223, BX478947, and Moshe) and several microRNAs (hsa-miR-19a, hsa-miR-19b, hsa-miR-375, hsa-miR-29c, miR-29, miR-143/145, miR-17-92, miR-106b-25, and miR-503/424, miR-9, miR-30a, miR-196a2, miR-139-5p, hsa-let-7a, hsa-let-7b, and hsa-miR-486) to ASD progression, corresponding to previous studies.

Conclusions: NcRNAs play a crucial role in unraveling the underlying mechanisms of ASD, contributing to both biomarker discovery and therapeutic advancements. This systematic review sheds light on the mechanisms of action of key ncRNAs involved in ASD progression, providing valuable insights for future research in this field.

References

Zhu S, Cao L, Zhu J, Kong L, Jin J, Qian L . Identification of maternal serum microRNAs as novel non-invasive biomarkers for prenatal detection of fetal congenital heart defects. Clin Chim Acta. 2013; 424:66-72. DOI: 10.1016/j.cca.2013.05.010. View

Aly D, Gohar N, Abd El-Hady A, Khairy M, Abdullatif M . Serum microRNA let-7a-1/let-7d/let-7f and miRNA 143/145 Gene Expression Profiles as Potential Biomarkers in HCV Induced Hepatocellular Carcinoma. Asian Pac J Cancer Prev. 2020; 21(2):555-562. PMC: 7332122. DOI: 10.31557/APJCP.2020.21.2.555. View

Matsson H, Eason J, Bookwalter C, Klar J, Gustavsson P, Sunnegardh J . Alpha-cardiac actin mutations produce atrial septal defects. Hum Mol Genet. 2007; 17(2):256-65. DOI: 10.1093/hmg/ddm302. View

Liu N, Tang L, Sun Y, Cui R, Wang H, Huang B . MiR-29c suppresses invasion and metastasis by targeting TIAM1 in nasopharyngeal carcinoma. Cancer Lett. 2012; 329(2):181-8. DOI: 10.1016/j.canlet.2012.10.032. View

Green D, Dalmay T, Chapman T . Microguards and micromessengers of the genome. Heredity (Edinb). 2015; 116(2):125-34. PMC: 4806885. DOI: 10.1038/hdy.2015.84. View

Huang S, Wu Y, Chen S, Yang Y, Wang Y, Wang H . Novel insertion mutation (Arg1822_Glu1823dup) in MYH6 coiled-coil domain causing familial atrial septal defect. Eur J Med Genet. 2021; 64(11):104314. DOI: 10.1016/j.ejmg.2021.104314. View

Zhang D, Wang B, Ma M, Yu K, Zhang Q, Zhang X . lncRNA HOTAIR Protects Myocardial Infarction Rat by Sponging miR-519d-3p. J Cardiovasc Transl Res. 2019; 12(3):171-183. DOI: 10.1007/s12265-018-9839-4. View

Jiang Y, Mo H, Luo J, Zhao S, Liang S, Zhang M . HOTAIR Is a Potential Novel Biomarker in Patients with Congenital Heart Diseases. Biomed Res Int. 2018; 2018:2850657. PMC: 5863312. DOI: 10.1155/2018/2850657. View

Yu K, Ji Y, Wang H, Xuan Q, Li B, Xiao J . Association of miR-196a2, miR-27a, and miR-499 polymorphisms with isolated congenital heart disease in a Chinese population. Genet Mol Res. 2016; 15(4). DOI: 10.4238/gmr15048929. View

10.

Bei Y, Lu D, Bar C, Chatterjee S, Costa A, Riedel I . miR-486 attenuates cardiac ischemia/reperfusion injury and mediates the beneficial effect of exercise for myocardial protection. Mol Ther. 2022; 30(4):1675-1691. PMC: 9077322. DOI: 10.1016/j.ymthe.2022.01.031. View

11.

Davis K, Azarcon P, Hickenlooper S, Bia R, Horiuchi E, Szulik M . The role of demethylases in cardiac development and disease. J Mol Cell Cardiol. 2021; 158:89-100. DOI: 10.1016/j.yjmcc.2021.05.018. View

12.

Malakootian M, Naeli P, Mowla S, Seidah N . Post-Transcriptional Effects of miRNAs on PCSK7 Expression and Function: miR-125a-5p, miR-143-3p, and miR-409-3p as Negative Regulators. Metabolites. 2022; 12(7). PMC: 9323720. DOI: 10.3390/metabo12070588. View

13.

Sun H, Dai J, Chen M, Chen Q, Xie Q, Zhang W . miR-139-5p Was Identified as Biomarker of Different Molecular Subtypes of Breast Carcinoma. Front Oncol. 2022; 12:857714. PMC: 9009410. DOI: 10.3389/fonc.2022.857714. View

14.

Song Y, Higgins H, Guo J, Harrison K, Schultz E, Hales B . Clinical significance of circulating microRNAs as markers in detecting and predicting congenital heart defects in children. J Transl Med. 2018; 16(1):42. PMC: 5828434. DOI: 10.1186/s12967-018-1411-0. View

15.

Yuan J, Yin C, Li Y, Song S, Fang G, Wang Q . EZH2 as an Epigenetic Regulator of Cardiovascular Development and Diseases. J Cardiovasc Pharmacol. 2021; 78(2):192-201. DOI: 10.1097/FJC.0000000000001062. View

16.

Gholipour A, Zahedmehr A, Shakerian F, Irani S, Oveisee M, Mowla S . Significance of microRNA-targeted ErbB signaling pathway genes in cardiomyocyte differentiation. Mol Cell Probes. 2023; 69:101912. DOI: 10.1016/j.mcp.2023.101912. View

17.

Dexheimer P, Cochella L . MicroRNAs: From Mechanism to Organism. Front Cell Dev Biol. 2020; 8:409. PMC: 7283388. DOI: 10.3389/fcell.2020.00409. View

18.

Chow L, Cook A, Ho S, Leung M, Anderson R . Isolated congenitally complete heart block attributable to combined nodoventricular and intraventricular discontinuity. Hum Pathol. 1998; 29(7):729-36. DOI: 10.1016/s0046-8177(98)90283-0. View

19.

Hatsuzawa K, Hirose H, Tani K, Yamamoto A, Scheller R, Tagaya M . Syntaxin 18, a SNAP receptor that functions in the endoplasmic reticulum, intermediate compartment, and cis-Golgi vesicle trafficking. J Biol Chem. 2000; 275(18):13713-20. DOI: 10.1074/jbc.275.18.13713. View

20.

Zhao J, Li L, Peng L . MAPK1 up-regulates the expression of MALAT1 to promote the proliferation of cardiomyocytes through PI3K/AKT signaling pathway. Int J Clin Exp Pathol. 2016; 8(12):15947-53. PMC: 4730081. View